STME — StimCell Enegetics Income Statement
0.000.00%
Last trade - 00:00- $5.65m
- $6.03m
- 13
- 36
- 50
- 23
Annual income statement for StimCell Enegetics, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.096 | 0.007 | 0.006 | 0.003 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.086 | 0.004 | 0.004 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.13 | 0.732 | 0.678 | 0.45 | 0.081 |
| Operating Profit | -1.04 | -0.725 | -0.672 | -0.448 | -0.081 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.09 | -0.911 | -0.697 | -0.495 | -0.142 |
| Net Income After Taxes | -1.09 | -0.911 | -0.697 | -0.495 | -0.142 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.09 | -0.911 | -0.697 | -0.495 | -0.142 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.09 | -0.911 | -0.697 | -0.495 | -0.142 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.326 | -0.182 | -0.167 | -0.118 | -0.031 |